Insider Trading & Ownership - Contineum Therapeutics Inc. (CTNM)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Contineum Therapeutics Inc.

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-24
Option Award
2024-06-24
4:25 pm
N/A
2034-06-23
Contineum Therapeutics Inc.CTNMBoyce Sarah
Director
29,500$029,500
(Direct)
View
2024-06-03
Option Award
2024-06-03
5:46 pm
N/A
2034-06-02
Contineum Therapeutics Inc.CTNMHealy John Stephen
General Counsel and Corp Sec
160,000$0160,000
(Direct)
View
2024-05-24
Option Award
2024-05-29
5:59 pm
N/A
2034-05-23
Contineum Therapeutics Inc.CTNMStengone Carmine N.
CEO and President
285,000$0285,000
(Direct)
View
2024-05-24
Option Award
2024-05-29
5:58 pm
N/A
2034-05-23
Contineum Therapeutics Inc.CTNMSlover Peter T
Chief Financial Officer
100,000$0100,000
(Direct)
View
2024-05-24
Option Award
2024-05-29
5:58 pm
N/A
2034-05-23
Contineum Therapeutics Inc.CTNMLorrain Daniel S.
Chief Scientific Officer
103,700$0103,700
(Direct)
View
2024-05-24
Option Award
2024-05-29
5:56 pm
N/A
2034-05-23
Contineum Therapeutics Inc.CTNMHuhn Stephen L.
CMO & Sr VP, Clinical Dev.
100,000$0100,000
(Direct)
View
2024-05-24
Option Award
2024-05-29
5:56 pm
N/A
2034-05-23
Contineum Therapeutics Inc.CTNMIgnelzi Troy A.
Director
6,350$06,350
(Direct)
View
2024-05-24
Option Award
2024-05-29
5:55 pm
N/A
2034-05-23
Contineum Therapeutics Inc.CTNMWare Olivia C
Director
3,700$03,700
(Direct)
View
2024-05-24
Option Award
2024-05-29
5:54 pm
N/A
2034-05-23
Contineum Therapeutics Inc.CTNMLyons-Williams Lori
Director
29,500$029,500
(Direct)
View
2024-05-24
Option Award
2024-05-29
5:54 pm
N/A
2034-05-23
Contineum Therapeutics Inc.CTNMBrady Todd R.
Director
29,500$029,500
(Direct)
View
2024-05-24
Option Award
2024-05-29
5:53 pm
N/A
2034-05-23
Contineum Therapeutics Inc.CTNMSchimmelpennink Evert B.
Director
29,500$029,500
(Direct)
View
2024-05-20
Option Award
2024-05-20
7:00 pm
N/A
2034-05-19
Contineum Therapeutics Inc.CTNMIgnelzi Troy A.
Director
23,150$023,150
(Direct)
View
2024-04-09
Conversion
2024-04-11
6:10 pm
N/A
N/A
Contineum Therapeutics Inc.CTNMVersant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Ventures IV LLC
10% Owner
5,483,756$010,101,912
(Indirect)
View

Ownership
2024-04-10
5:05 pm
N/A
N/A
Contineum Therapeutics Inc.CTNMJOHNSON & JOHNSON
Johnson & Johnson Innovation - JJDC Inc.
10% Owner
0$01,979,173
(Indirect)
View

Ownership
2024-04-04
9:22 pm
N/A
N/A
Contineum Therapeutics Inc.CTNMVersant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Venture Capital IV L.P.
Versant Side Fund IV L.P.
Versant Ventures IV LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
10% Owner
0$05,316,663
(Direct)
View

Ownership
2024-04-04
5:59 pm
N/A
2034-03-26
Contineum Therapeutics Inc.CTNMWare Olivia C
Director
0$029,479
(Direct)
View

Ownership
2024-04-04
5:59 pm
N/A
2032-01-17
Contineum Therapeutics Inc.CTNMSchimmelpennink Evert B.
Director
0$032,090
(Direct)
View

Ownership
2024-04-04
5:58 pm
N/A
2030-08-11
Contineum Therapeutics Inc.CTNMLyons-Williams Lori
Director
0$029,478
(Indirect)
View

Ownership
2024-04-04
5:56 pm
N/A
2034-03-26
Contineum Therapeutics Inc.CTNMBrady Todd R.
Director
0$029,479
(Direct)
View

Ownership
2024-04-04
5:54 pm
N/A
2030-02-24
Contineum Therapeutics Inc.CTNMHuhn Stephen L.
CMO & Sr VP, Clinical Dev.
0$0236,725
(Direct)
View

Ownership
2024-04-04
5:52 pm
N/A
2030-10-05
Contineum Therapeutics Inc.CTNMSlover Peter T
Chief Financial Officer
0$0237,618
(Direct)
View

Ownership
2024-04-04
5:51 pm
N/A
N/A
Contineum Therapeutics Inc.CTNMLorrain Daniel S.
Chief Scientific Officer
0$0670,865
(Direct)
View

Ownership
2024-04-04
5:49 pm
N/A
N/A
Contineum Therapeutics Inc.CTNMStengone Carmine N.
CEO and President
0$0981,519
(Direct)
View